|
Search
Search through the thousands of lawsuits, complaints and recalls on our site.
 |
Case ID: 3090 | Stocks | 01/26/2004
Several class actions have been filed against healthcare facility operator Dynacq International (Nasdaq: DYIIE, formerly Nasdaq: DYII) and certain of its officers and directors by stockholders who purchased the company's common stock between January 14, 2003, and December 18, 2003. The actions claim that the defendants fraudulently certified that Dynacq's financial statements for the first three quarters of fiscal 2003 were compiled in compliance with Generally Accepted Accounting Principles. The stockholders seek to recover compensatory damages for the loss of value of their stock.
The true facts were first revealed beginning on December 2, 2003, when the Dynacq announced that it was requesting an automatic extension of up to 15 days to file its Form 10-K for fiscal year ended August 31, 2003, with the SEC. On December 18, 2003, the company announced that its independent auditor, Ernst & Young, LLP, had resigned due to the Dynacq’s lack of internal controls necessary to develop reliable financial statements.' It also announced that it had received a Nasdaq Staff Determination stating that its stock might be de-listed on December 30, 2003, due to Dynacq's failure to file its fiscal year 2003 10-K in a timely manner. The same day, the company announced that it had received notice that the SEC was conducting an investigation into its reporting of its financial statements, revenue and cost recognition, allowances for doubtful accounts, and internal financial and accounting controls. The market reacted negatively to these disclosures. Dynacq shares, after trading during the applicable period at a high of $27.37 per share, plummeted to a low of just $4.09 per share on December 19, 2003. If you purchased or otherwise acquired Dynacq securities during the period described above, you may request that the court appoint you as a lead plaintiff, but you must do so no later than February 24, 2004. At Lawcash.com, it is our goal to keep you informed about important legal cases, class actions and settlements. Our lawyers offer free legal evaluations in tort cases, class actions, personal injury, and other lawsuits because we are dedicated to helping you resolve your legal complaints. Other Stocks Cases of Interest A class action has been filed against Immucor, Inc. (BLUD), certain of its officers and directors by stockholders who purchased the company's common stock between January 7, 2005 and August 29, 2005. The action claims that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. The stockholders seek to recover compensatory damages for the loss of value of their stock. A class action has been filed against ProQuest Company (PQE), certain of its officers and directors by stockholders who purchased the company's common stock between January 9, 2003 and February 8, 2006. The action claims that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. The stockholders seek to recover compensatory damages for the loss of value of their stock. Semiconductor technology changes very rapidly—cutting edge companies are developing faster and better materials and designs constantly. Several class actions have been filed against semiconductor wafer manufacturer IBIS Technology Corporation (Nasdaq: IBIS) and certain of its officers and directors by stockholders who purchased the company's common stock between October 2, 2003, and December 12, 2003. The actions claim that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. A class action has been filed against Bank One Corporation (NYSE: ONE) and certain related firms by investors who purchased shares in any of the One Group mutual funds, managed by Bank One, between October 1, 1998, and July 3, 2003. The action charges that, throughout this time period, the defendants failed to disclose that they improperly allowed certain hedge funds, such as Canary Capital Partners, to engage in "late trading" and "timing" of the funds' securities. A class action has been filed against Noven Pharmaceuticals, Inc. (Nasdaq: NOVN) and certain of its officers and directors by stockholders who purchased the company's common stock between October 29, 2001, and April 28, 2003.
A class action has been filed against World Health Alternatives, Inc. (WHAIE.OB), certain of its officers and directors by stockholders who purchased the company's common stock between October 7, 2003 and August 18, 2005. The action claims that the defendants violated federal securities laws by issuing a series of material misrepresentations to the market over this time period, thereby artificially inflating the price of the company's securities. The stockholders seek to recover compensatory damages for the loss of value of their stock.
|
IT'S FREE
|
© 2000 - 2008 Copyright. All rights reserved nola3, llc.
